Lobby organisation
Pfizer Inc.
Company · Health & pharma · HQ: United States · Transparency Register entry
As of 7 November 2026, Pfizer Inc. appears in 48 declared MEP meetings (31 different MEPs), most often with European People's Party.
In their own words
“At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines.”
Read the rest of the statementShow less of the statement
“Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 48 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2021–2026. Bar length is relative to its busiest year (16 in 2025). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 15 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 28 Oct 2026 | Wouter Beke | EU Biotech Act I |
| 20 Oct 2026 | Tiemo Wölken | MDR/IVDR Revision and Biotech Act |
| 9 Jun 2026 | Andreas Glück | MDR revision |
| 28 Apr 2026 | Ingeborg ter Laak | Biotech Act |
| 15 Apr 2026 | Wouter Beke | Biotech Act I |
| 26 Mar 2026 | Vytenis Povilas Andriukaitis | Biotech Act |
| 17 Feb 2026 | Beatrice Timgren | Challenges with Packaging |
| 4 Feb 2026 | Stine Bosse | AMR |
| 25 Nov 2025 | Andi Cristea | Recent developments in EU-US trade policy |
| 8 Oct 2025 | Hildegard Bentele | Biotech |
| 1 Jul 2025 | András Tivadar Kulja | Critical medicines act |
| 11 Jun 2025 | Margarita de la Pisa Carrión | Beating Cancer Plan |
| 4 Jun 2025 | Tomislav Sokol | Health policy |
| 4 Jun 2025 | Romana Jerković | Critical Medicines Act |
| 21 May 2025 | Andreas Glück | CMA |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.